No Detail Found!

Anticardiolipin antibodies as additional risk factor in proliferative diabetic retinopathy

Author(s)
HOORIA AAMIR Punjab Medical College Faisalabad, Pakistan
AMTUL HUDA Abbottabad International Medical and Dental Colleges, Pakistan
MEMON MUHAMMAD KHAN Hera General hospital, Holy Makkah, KSA
FAUZIA AITAZAZ Azad Jammu Kashmir Medical College Muzaffarabad AK
ZULFIQAR ALI Avicenna Medical College, Lahore, Pakistan
AFSHEEN AKBAR Avicenna Medical College, Lahore, Pakistan
MINAHAL SHAUKAT University Medical & Dental College, Faisalabad, Pakistan
Abstract
Aim: In patients of proliferative diabetic retinopathy (PDR) the prevalence of anticardiolipin antibodies (aCL) account as high-risk criterion (HRC).1 Methods: Both groups of Diabetic and non diabetics patients contain PDR by way of HRC and were compared for anticardiolipin antibodies presence. Results: Amongst the 40 patients, 9(22.5%) of the diabetic subjects having PDR with HRC had anticardiolipin antibodies positive results. There were no significant relationships of (aCL) antibodies with type of diabetes or gender. By using Pearson's association test, no significant relations of (aCL) antibodies with diabetes or age of subject would be establish. Statistically significant difference was found in all subjects with positive results of (aCL) had PDR along with HRC. Conclusion: Presence of anticardiolipin antibodies (aCL) may signify as a supplementary risk factor for PDR.
Publication Details
Page(s) 179-181
DOI DOI not available
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 14, Issue: 1, Year: 2020

Request the full text from PASTIC

Keywords
proliferative diabetic retinopathy, high-risk criterion., Intravitreal vascular endothelial growth factor, Anticardiolipin antibodies, Antiphospholipid antibodies (APLA)
0

Citations

0

Downloads

60

Views